Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAK Concentration Comparison in Post-Cataract Surgery
NCT06404541Phase 4Active, not recruiting
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jan 2024
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of netilmicin, dexamethasone in post-operative ocular inflammation, ocular infection, sponsored by Kasr Al Ainy Hospital. Started Jan 2024; status: active, not recruiting.
02
Drugs
netilmicindexamethasone
03
Conditions
post-operative ocular inflammationocular infection
Beyond the preview
Go deeper on NCT06404541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06404541.